Relmada Therapeutics (RLMD) Financials

$4.43

$0.06 (1.37%)

As on 04-Sep-2026 16:00EDT

Market cap

$473 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20	Dec-19
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	65.13	59.10	83.89	103.70	161.25	125.70
Operating Profit (EBIT)	-65.13	-59.10	-83.89	-103.70	-161.25	-125.70
Other Income	--	--	--	--	1.55	--
Profit before Tax	-61.93	-57.39	-79.98	-98.79	-157.04	-125.75
Provision for Tax	--	--	--	-0.10	-2.66	--
Profit after Tax (Net Income)	-61.93	-57.39	-79.98	-98.79	-157.04	-125.75
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-157.04	-125.75

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20	Dec-19
Shareholder's Funds	206.56	86.51	35.52	85.36	140.44	208.26
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	5.08	1.06	0.00	--	0.00	--
Current Liabilities	7.42	6.43	10.29	12.19	12.47	15.06
Total Liabilities	226.48	94.00	45.82	97.55	152.91	223.33

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20	Dec-19
Non-Current Assets	0.02	0.02	0.02	0.04	0.03	0.03
Current Assets	219.04	93.98	45.80	97.51	152.87	223.30
Total Assets	226.48	94.00	45.82	97.55	152.91	223.33
Total Debt*	--	--	--	--	--	--
Net Current Assets	211.62	87.55	35.50	85.31	140.40	208.24

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20	Dec-19
Cash From Operating Activities	--	-45.79	-51.76	-51.66	-103.80	-91.87
Cash Flow from Investing Activities	--	-48.14	51.56	50.45	19.73	-54.12
Cash from Financing Activities	--	93.56	-0.04	-0.10	45.02	187.94
Net Cash Inflow / Outflow	--	--	--	--	-39.05	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20	Dec-19
Adjusted EPS ($)	-0.93	-0.84	-2.65	-3.28	-5.22	-4.19
Cash EPS ($)	--	-0.84	-2.65	-3.28	-5.22	-4.19
Adjusted Book Value ($)	--	1.27	1.18	2.84	4.67	6.94
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.67	-1.72	-1.72	-3.45	-3.06
Free Cash Flow per Share ($)	--	-0.67	-1.72	-1.72	-3.45	-3.06

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20	Dec-19
ROCE (%)	--	-94.05	-132.33	-87.51	-90.07	-80.14
ROE (%)	-42.26	-94.05	-132.33	-87.51	-90.07	-80.14
ROA (%)	-49.01	-82.08	-111.57	-78.89	-83.48	-73.64
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	-10,159.14	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20	Dec-19
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	--	--	19.04	37.09	-24.88	-114.53
Net Profit Growth (%)	8.68	28.25	19.04	37.09	-24.88	-111.50
EPS Growth (%)	57.97	0.68	0.19	0.37	0.21	-0.20
Book Value Growth (%)	282.52	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20	Dec-19
Price / Earnings	--	-5.74	-0.20	-1.26	-0.67	-4.53
Price / Book Value	2.30	3.81	0.44	1.46	0.75	2.74
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.54	-4.12	0.37	5.76	0.28	-2.87
Close Price ($)	6.92	4.83	0.52	4.14	3.49	18.99
High Price ($)	8.00	5.12	7.22	4.85	38.68	35.35
Low Price ($)	0.55	0.24	0.34	2.00	1.81	15.74
Market Cap ($ Cr)	472.55	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20	Dec-19
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	29.52	14.62	4.45	8.00	12.26	14.83
Quick Ratio	29.52	--	--	--	11.94	--
Interest Coverage	--	--	--	--	-37.34	-103.87

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Jun-22	Dec-21	Jun-21	Dec-20	Jun-20	Dec-19
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.